Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice
Ozempic (semaglutide) [package insert]
While no tanning pills are approved by the FDA, lycopene and astaxanthin arent even marketed (and therefore are likely not being tested) for skin darkening and they definitely arent providing any protection against the sun
As strategic partners, Omada and Express Scripts are here to help roll out these medications responsibly
Published trials are sparse, but a 2023 observational study reported modest additional weight loss (35 lbs over 12 weeks) with combination therapy versus single-agent, though nausea and dizziness occurred in 34% of patients
Graphic by Clara Turnage/University Marketing and Communications By Clara Turnage Campus Office, Department or Center Published July 20, 2026